Abstract

The NYU-HHC Clinical and Translational Science Institute (CTSI), directed by Drs. Judith Hochman and Bruce Cronstein, represents a strategic public-private alliance between two of New York's leading institutions in the service of the people of the city. New York University (“NYU”), founded in 1831, is the country's largest private university with 14 schools and over 40,000 students in New York City. The New York City Health and Hospitals Corporation (“HHC”) is the largest public health care delivery system in the United States, overseeing eleven acute-care hospitals, six diagnostic and treatment centers, four long term care centers, one hundred community health centers, a certified home health agency, and a managed care plan for 450,000 enrollees. In 2011, the HHC Emergency Departments alone provided care to more than one million patients. Of the eleven acute care hospitals, eight are included in the NYU-HHC CTSI: Bellevue Hospital Center, Coler-Goldwater Specialty Hospital and Nursing Facility, Coney Island Hospital, Gouverneur Diagnostic and Treatment Center, Kings County Hospital Center, Lincoln Medical and Mental Health Center, Metropolitan Hospital Center and Woodhull Medical and Mental Health Center. The CTSI offers multi-faceted support for clinical and translational research. Our Clinical Research Center is currently housed in a 3,200sf space within Bellevue Hospital but will soon move to a 9,000sf space that was newly renovated to better support the types of research carried out on our unit. The NYU-HHC CTSI has a strong educational component, supporting both degree-granting and certificate programs in Clinical Investigation, Comparative Effectiveness Research and Population Health. In addition, strong and successful programs designed to develop investigative careers by residents, fellows and junior faculty are in place. The Center for Health Informatics and Bioinformatics (CHIBI) offers state of the art informatics support for analysis of large datasets, examining best practices in informatics and examination of the success of analytic software. NYU School of Medicine has been in the forefront of efforts to forge academic-industry alliances with ongoing programs in collaboration with Pfizer and a strong history of developing technologies which have been licensed to Pharma where they were developed into therapies to benefit patients. One of the unique strengths of the NYU-HHC CTSI is our Community Engagement and Population Health Research Core which, in combination with the partnership with NYC Health and Hospitals Corporation, has the ability to promote community-based research in our diverse communities, determine the most pressing areas of research for each of our communities, and promote the well-being of the citizens of our great city.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call